SynthesisAging2023

The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis.

Jiaxin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.